Flash e-reader

 Go to e-reader chapter








Table 10.6d

Immunosuppression Use for Maintenance by Regimen

Prior to Discharge, 2000 to 2009

Recipients with Intestine Transplants

  Transplant Year
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009
Functioning Graft at Discharge 61 88 89 103 130 155 148 166 168 154
With Immunosuppression Info 61 88 89 103 127 152 148 166 167 154
Tac 1.6% 18.2% 31.5% 30.1% 22.8% 25.7% 16.9% 11.4% 10.2% 15.6%
--- + MMF/MPA 1.6% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.6%
Tac + MMF/MPA 0.0% 0.0% 0.0% 0.0% 0.0% 1.3% 7.4% 11.4% 10.8% 18.8%
Tac + Siro/Evero 0.0% 2.3% 0.0% 0.0% 2.4% 2.0% 2.0% 0.0% 0.6% 0.0%
Tac + MMF/MPA + Siro/Evero 0.0% 0.0% 0.0% 1.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
--- + Steroids 0.0% 1.1% 2.2% 3.9% 0.8% 2.0% 1.4% 1.8% 0.0% 0.6%
CyA + Steroids 0.0% 0.0% 0.0% 1.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Tac + Steroids 41.0% 48.9% 36.0% 50.5% 55.9% 47.4% 52.7% 56.0% 55.1% 45.5%
--- + MMF/MPA + Steroids 0.0% 0.0% 0.0% 0.0% 0.0% 0.7% 0.7% 0.0% 0.6% 0.0%
Tac + MMF/MPA + Steroids 13.1% 3.4% 7.9% 6.8% 8.7% 10.5% 10.1% 8.4% 12.6% 16.2%
--- + OtherAntimet + Steroids 1.6% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Tac + OtherAntimet + Steroids 0.0% 6.8% 0.0% 0.0% 0.0% 0.0% 0.7% 1.8% 0.0% 0.0%
--- + Siro/Evero + Steroids 1.6% 1.1% 0.0% 0.0% 1.6% 0.7% 0.0% 0.0% 0.0% 0.0%
Tac + Siro/Evero + Steroids 34.4% 18.2% 15.7% 3.9% 7.9% 9.9% 7.4% 7.8% 9.0% 2.6%
Other Regimen 4.9% 0.0% 6.7% 2.9% 0.0% 0.0% 0.7% 1.2% 1.2% 0.0%


Source: OPTN/SRTR Data as of October 1, 2010.

Percentages in each column sum to 100 percent.

---: No Calcineurin Inhibitor Use; CyA: Cyclosporine; Tac: Tacrolimus.

MMF: Mycophenolate Mofetil; MPA: Mycophenolate Sodium; Siro: Sirolimus; Evero: Everolimus; OtherAntimet: Antimetabolites excluding MMF and MPA.

"Other Regimen" includes drug combinations that are different from the listed regimens and drugs from the text field entering.